-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Revelation Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2024.
- Revelation Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.75M, a 24.6% increase year-over-year.
- Revelation Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$7.98M, a 7.87% increase year-over-year.
- Revelation Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$7.98M, a 7.87% increase from 2023.
- Revelation Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$8.66M, a 20.3% increase from 2022.
- Revelation Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$10.9M, a 9.09% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)